3^rd Edition of Infectious Diseases World Conference 2027

Precision medicine brings revolutionary changes in the treatment of infectious diseases by providing individualized approaches based on unique patient features, pathogen characteristics, genetic background, and immunity. Modern achievements in molecular diagnostics, pharmacogenomics, and discovery of biomarkers contribute to a more profound knowledge of the differences between disease development and drug response. In this session, we will discuss how a personalized approach can help select an appropriate therapy and manage difficult infectious cases.

In this session, participants will consider recent results related to host-pathogen interactions, individual risks factors, therapeutic drug monitoring, and biomarkers that indicate the severity of diseases and drug response. It will discuss how genomic information can be used for the identification of patients' susceptibility to infections, the prediction of treatment, and the need for individual approaches to management. The challenges and opportunities of applying precision medicine in everyday clinical practice will also be considered.

Researchers, clinicians, microbiologists, pharmacologists, and health care providers are welcome to submit studies related to individualized treatment, precision diagnostics, and rational drug prescription for infectious diseases.